A method and system for changing the usage scenarios of CGM equipment
By generating an authorization key to utilize the remaining usage time of the CGM device, the problem of resource waste of the CGM device when patients are discharged is solved, realizing efficient use of the device and continuity of blood glucose monitoring, and reducing medical costs.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-22
- Publication Date
- 2026-04-03
AI Technical Summary
The lifespan of existing CGM equipment usually exceeds the length of a patient's hospital stay, resulting in unused remaining effective time at discharge, which leads to resource waste and increased medical costs.
An authorization key is generated by obtaining the unique serial number and current parameters of the CGM device, allowing the patient to continue using the device in the second scenario until the end of the usage period. This key includes the device model, sensor model, and remaining usage time. The authorization key can be a barcode or QR code.
This enables efficient use of CGM equipment resources, reduces medical costs, improves the continuity and effectiveness of blood glucose monitoring, and provides patients with an economical and convenient way to manage blood glucose.
Smart Images

Figure CN119380963B_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of testing equipment technology, and in particular to a method and system for changing the usage scenario of a CGM device. Background Technology
[0002] Continuous glucose monitoring (CGM) devices provide hospitalized diabetic patients with a more accurate, safe, and efficient means of monitoring blood glucose. This monitoring technology has a significant positive impact on improving patients' treatment outcomes and quality of life. The operation procedure is as follows: First, the nurse selects the patient in the CGM system and binds the CGM device with a unique number. The patient's CGM device then uploads the monitoring data to the blood glucose data management system in real time via a Bluetooth gateway. Upon discharge, medical staff are responsible for marking the end of monitoring in the system, and the nurse is responsible for removing the CGM device from the patient.
[0003] However, CGM devices currently on the market are typically designed for use over a period of more than 14 days, while the average hospital stay for diabetic patients is about 7 days. Therefore, when patients are discharged, the CGM devices often still have remaining effective usage time, which may lead to underutilization of resources.
[0004] Therefore, providing a method and system for converting the usage scenarios of CGM devices to make full use of their remaining time is a technical problem that urgently needs to be solved by those skilled in the art. Summary of the Invention
[0005] To address the aforementioned technical problems, the present invention aims to provide a method and system for switching the usage scenarios of CGM devices, which is intended to make full use of the remaining effective usage time of continuous glucose monitoring (CGM) devices. This not only helps patients reduce medical expenses but also promotes efficient use of resources and improves the rate of achieving blood glucose control targets.
[0006] The first objective of this invention is to provide a method for changing the usage scenario of a CGM device;
[0007] The technical solution provided by this invention is as follows:
[0008] A method for changing the usage scenario of a CGM device includes the following steps:
[0009] Obtain the unique serial number of the CGM device worn by the patient in the first scenario;
[0010] The current parameters of the CGM device are obtained based on the unique number;
[0011] Generate an authorization key for the second scenario based on the current parameters;
[0012] The patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the CGM device usage cycle ends.
[0013] The current parameters include the duration of use, device model, and sensor model.
[0014] The authorization key is a barcode or a QR code.
[0015] Preferably, the first scenario is the usage scenario of the CGM device in its first cycle.
[0016] Preferably, the second scenario is the usage scenario of the second cycle following the first cycle.
[0017] Preferably, obtaining the unique identifier of the CGM device worn by the patient in the first scenario specifically includes:
[0018] When the CGM management module receives a patient's discharge instruction, it retrieves the unique serial number of the CGM device worn by the patient.
[0019] Preferably, before obtaining the current parameters of the CGM device based on the unique number, the method further includes the following steps:
[0020] The CGM management module sends the unique number and scene conversion instruction to the Bluetooth gateway, and the Bluetooth gateway disconnects from the CGM device based on the unique number and scene conversion instruction.
[0021] Preferably, obtaining the current parameters of the CGM device based on the unique number specifically includes:
[0022] After the Bluetooth gateway successfully disconnects, the CGM management module calculates the current parameters of the CGM device.
[0023] Preferably, generating the authorization key for the second scenario based on the current parameters specifically includes:
[0024] If the current parameter is less than the usage cycle of the CGM device, the CGM management module will automatically generate an authorization key for the second scenario;
[0025] The authorization key includes: the device's unique serial number, remaining usage time, device connection instructions, and the latest blood glucose data.
[0026] Preferably, the patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the CGM device's usage cycle ends, specifically including:
[0027] The patient scans the authorization key through a user terminal to obtain the device's unique serial number, device connection instructions, and remaining usage time.
[0028] The user terminal decodes the acquired unique device number, device connection command, and remaining usage time.
[0029] Preferably, the patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the end of the CGM device's usage cycle, which further includes:
[0030] The user terminal verifies the decoded information:
[0031] If the verification passes, a connection command is sent to the CGM device to bind the CGM device;
[0032] Once the binding is successful, the patient continues to use the CGM device for blood glucose monitoring in the second scenario until the CGM device usage cycle ends.
[0033] The second objective of this invention is to provide a usage scenario conversion system for CGM devices;
[0034] The technical solution provided by this invention is as follows:
[0035] A CGM device usage scenario conversion system, based on any of the steps of the CGM device usage scenario conversion method, includes: a CGM management module, a Bluetooth gateway, and a user terminal;
[0036] The CGM management module is connected to the CGM device, the Bluetooth gateway, and the user terminal, respectively.
[0037] The Bluetooth gateway is connected to the CGM device;
[0038] The CGM management module is used to obtain the unique number of the CGM device worn by the patient and send the unique device number and scene switching command to the Bluetooth gateway;
[0039] The CGM management module is also used to calculate the current parameters of the CGM device and generate an authorization key for the second scenario;
[0040] The Bluetooth gateway is configured to stop receiving blood glucose data detected by the CGM device and disconnect the Bluetooth connection of the CGM device after receiving the scene switching instruction.
[0041] The user terminal is used to scan the authorization key, enabling the patient to continue using the CGM device for blood glucose monitoring in the second scenario until the CGM device's usage cycle ends.
[0042] This invention provides a method for switching usage scenarios of a CGM device. The method involves obtaining the unique serial number of the CGM device worn by the patient in a first scenario; obtaining the current parameters of the CGM device based on the unique serial number; generating an authorization key for a second scenario based on the current parameters; and allowing the patient to continue using the CGM device for blood glucose monitoring in the second scenario using the authorization key until the end of the CGM device's usage period. This method optimizes the usage process of continuous glucose monitoring (CGM) devices, achieving savings in medical resources and improving the patient's monitoring experience. Instead of removing the CGM device upon discharge, the patient can continue using the device in the second scenario until its usage period ends by generating an authorization key based on the current parameters. This improves the continuity and effectiveness of blood glucose monitoring, while reducing medical costs and providing a more economical and convenient way for diabetic patients to manage their blood glucose.
[0043] The present invention also provides a usage scenario conversion system for CGM equipment. Since this system and the usage scenario conversion method for CGM equipment solve the same technical problem and belong to the same technical concept, they should have the same beneficial effects, and will not be described in detail here. Attached Figure Description
[0044] To more clearly illustrate the technical solutions in the embodiments of this application or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in this application. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0045] Figure 1 This is a flowchart of a method for changing the usage scenario of a CGM device according to an embodiment of the present invention;
[0046] Figure 2 This is a schematic diagram of the usage scenario conversion system of a CGM device according to an embodiment of the present invention;
[0047] Figure 3 This is a schematic diagram of the specific structure of a CGM device usage scenario conversion system according to an embodiment of the present invention. Detailed Implementation
[0048] To enable those skilled in the art to better understand the technical solutions in this application, the technical solutions in the embodiments of this application will be clearly and completely described below. Obviously, the described embodiments are only a part of the embodiments of this application, and not all of the embodiments. Based on the embodiments in this application, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this application.
[0049] It should be noted that when a component is referred to as being "fixed to" or "set on" another component, it can be directly on or indirectly set on the other component; when a component is referred to as being "connected to" another component, it can be directly connected to or indirectly connected to the other component.
[0050] It should be understood that the terms "length", "width", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing this application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this application.
[0051] Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of this application, "a plurality of" or "several" means two or more, unless otherwise explicitly specified.
[0052] It should be noted that the structures, proportions, sizes, etc., shown in the accompanying drawings of this specification are only for the purpose of assisting those skilled in the art in understanding and reading the content disclosed in the specification, and are not intended to limit the conditions under which this application can be implemented. Therefore, they have no substantial technical significance. Any modifications to the structure, changes in the proportions, or adjustments to the size should still fall within the scope of the technical content disclosed in this application, provided that they do not affect the effects and purposes that this application can produce.
[0053] like Figure 1 As shown, this embodiment of the invention provides a method for changing the usage scenario of a CGM device, including the following steps:
[0054] S1. Obtain the unique serial number of the CGM device worn by the patient in the first scenario;
[0055] In step S1, when a patient is hospitalized, medical staff will put a CGM device on the patient. Therefore, it is necessary to obtain the unique number corresponding to the CGM device worn by the patient in the first scenario, so as to facilitate the next step of processing based on the unique number.
[0056] S2. Obtain the current parameters of the CGM device based on the unique number;
[0057] S3. Generate the authorization key for the second scenario based on the current parameters;
[0058] In steps S2 to S3, the current parameters of the corresponding CGM device will be calculated based on the unique number obtained in step S1; then, an authorization key for the second scenario will be generated based on the current parameters, so that the patient can continue to use the CGM device in the second scenario; wherein, the current parameters include the usage time, device model and sensor model; the authorization key is a barcode or QR code; the authorization key can also be a string.
[0059] S4. The patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the CGM device usage cycle ends.
[0060] In step S4, when the patient is discharged, the medical staff do not need to remove the CGM device. Instead, they can continue to use the CGM device for blood glucose monitoring in the second scenario using the authorization key obtained in step S3, until the CGM device usage cycle ends.
[0061] Compared with existing technologies, this method optimizes the usage process of continuous glucose monitoring (CGM) devices, saving medical resources and improving the patient monitoring experience. The CGM device is not removed upon discharge. Instead, an authorization key for a second scenario is generated based on the current parameters, allowing the patient to continue using the device in the second scenario until its expiration date. This improves the continuity and effectiveness of glucose monitoring, while reducing medical costs and providing a more economical and convenient way for diabetic patients to manage their blood glucose.
[0062] Preferably, the first scenario is the usage scenario of the CGM device in its first cycle.
[0063] In practical applications, the scenario transition in this embodiment can be from within a hospital to outside a hospital, from outside a hospital to within a hospital, or between different hospitals. Since CGM devices generally have a 14-day usage cycle, the first scenario is the usage scenario of the CGM device in the first cycle. For example, if the first cycle is used in a hospital, then the hospital is the first scenario.
[0064] Preferably, the second scenario is the usage scenario of the second cycle following the first cycle.
[0065] In practical application, the second scenario is the usage scenario following the end of the first cycle. For example, if the second cycle is used at the patient's home, then the patient's home is the second scenario.
[0066] Preferably, obtaining the unique identifier of the CGM device worn by the patient in the first scenario specifically includes:
[0067] When the CGM management module receives a patient's discharge instruction, it retrieves the unique serial number of the CGM device worn by the patient.
[0068] In practical application, when a patient is discharged, medical staff will send the patient's discharge instruction to the CGM management module. When the CGM management module receives the patient's discharge instruction, it will query the unique number of the CGM device worn by the patient.
[0069] Preferably, before obtaining the current parameters of the CGM device based on the unique number, the method further includes the following steps:
[0070] The CGM management module sends the unique number and scene conversion instruction to the Bluetooth gateway, and the Bluetooth gateway disconnects from the CGM device based on the unique number and scene conversion instruction.
[0071] In practical application, the CGM management module sends the device's unique number and scene switching command to the Bluetooth gateway. After receiving the command, the Bluetooth gateway stops receiving blood glucose data generated by this device and disconnects the Bluetooth connection of this device. The Bluetooth gateway used in this implementation is responsible for establishing a connection with the CGM device worn by the patient in the ward through Bluetooth technology and collecting blood glucose monitoring data in real time.
[0072] Preferably, obtaining the current parameters of the CGM device based on the unique number specifically includes:
[0073] After the Bluetooth gateway successfully disconnects, the CGM management module calculates the current parameters of the CGM device.
[0074] In practical applications, after the Bluetooth gateway successfully disconnects, the CGM management module calculates the current patient parameters of the CGM device corresponding to the unique number, which facilitates the next step of the operation.
[0075] Preferably, generating the authorization key for the second scenario based on the current parameters specifically includes:
[0076] If the current parameter is less than the usage cycle of the CGM device, the CGM management module will automatically generate an authorization key for the second scenario;
[0077] The authorization key for the second scenario includes: the device's unique serial number, remaining usage time, device connection instructions, and the latest blood glucose data.
[0078] In practical application, the system judges based on the current parameters. If the current parameters are less than the usage cycle of the CGM device, the CGM management module will automatically generate an authorization key for the second scenario. The authorization key includes: the device's unique number, remaining usage time, device connection instructions, and the latest blood glucose data.
[0079] Preferably, the patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the CGM device's usage cycle ends, specifically including:
[0080] The patient scans the authorization key for the second scenario through the user terminal to obtain the device's unique number, device connection instructions, and remaining usage time;
[0081] The user terminal decodes the acquired unique device number, device connection command, and remaining usage time.
[0082] In practical application, the patient scans the authorization key of the second scenario through the user terminal to obtain the unique number of the CGM device, the device connection command, and the remaining usage time; then the user terminal decodes the obtained unique number of the CGM device, the device connection command, and the remaining usage time; in this embodiment, the user terminal is a health management software that patients can use at home, which can synchronize with smart devices to record and manage key health indicators such as blood sugar and blood pressure.
[0083] Preferably, the patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the end of the CGM device's usage cycle, which further includes:
[0084] The user terminal verifies the decoded information:
[0085] If the verification passes, a connection command is sent to the CGM device to bind the CGM device;
[0086] Once the binding is successful, the patient continues to use the CGM device for blood glucose monitoring in the second scenario until the CGM device usage cycle ends.
[0087] In practical applications, the user terminal needs to verify the decoded information. If the verification passes, a connection command is sent to the CGM device to bind the CGM device. Once the binding is successful, the patient continues to use the CGM device for blood glucose monitoring in the second scenario. The user terminal can receive blood glucose data generated by the CGM device in real time until the end of the CGM device's usage cycle. This optimizes the usage process of continuous glucose monitoring (CGM) devices, saving medical resources and improving the patient's monitoring experience.
[0088] like Figures 2 to 3 As shown, this embodiment of the invention provides a CGM device usage scenario conversion system, based on any of the method steps of the CGM device usage scenario conversion method, including: a CGM management module, a Bluetooth gateway, and a user terminal;
[0089] The CGM management module is connected to the CGM device, the Bluetooth gateway, and the user terminal, respectively.
[0090] The Bluetooth gateway is connected to the CGM device;
[0091] The CGM management module is used to obtain the unique number of the CGM device worn by the patient and send the unique device number and scene switching command to the Bluetooth gateway;
[0092] The CGM management module is also used to calculate the current parameters of the CGM device and generate an authorization key for the second scenario;
[0093] The Bluetooth gateway is configured to stop receiving blood glucose data detected by the CGM device and disconnect the Bluetooth connection of the CGM device after receiving the scene switching instruction.
[0094] The user terminal is used to scan the authorization key, enabling the patient to continue using the CGM device for blood glucose monitoring in the second scenario until the CGM device's usage cycle ends.
[0095] In practical application, the CGM device usage scenario switching system includes a CGM management module, a Bluetooth gateway, and a user terminal. The CGM management module connects to the CGM device, Bluetooth gateway, and user terminal. The Bluetooth gateway connects to the CGM device. The CGM management module obtains the unique serial number of the CGM device worn by the patient and sends this serial number along with a scenario switching command to the Bluetooth gateway. Upon receiving the scenario switching command, the Bluetooth gateway stops receiving blood glucose data detected by the CGM device and disconnects the Bluetooth connection of the CGM device. Finally, the CGM management module calculates the current parameters of the CGM device and generates an authorization password for the second scenario. The system utilizes a user terminal to scan an authorization key, enabling patients to continue using the CGM device for blood glucose monitoring in a second scenario until the device's usage period ends. This system optimizes the usage process of continuous glucose monitoring (CGM) devices, saving medical resources and improving the patient's monitoring experience. The CGM device is not removed upon discharge; instead, through the collaborative work of the CGM management module, Bluetooth gateway, and user terminal, patients can continue using the device in a second scenario until its expiration date. This improves the continuity and effectiveness of blood glucose monitoring while reducing medical costs, providing a more economical and convenient blood glucose management solution for diabetic patients.
[0096] In the embodiments provided in this application, it should be understood that the disclosed methods and systems can be implemented in other ways. The system embodiments described above are merely illustrative. For example, the division of modules is only a logical functional division, and in actual implementation, there may be other division methods, such as: multiple modules or components can be combined, or integrated into another system, or some features can be ignored or not executed. In addition, the coupling, direct coupling, or communication connection between the various components shown or discussed can be through some interfaces, indirect coupling or communication connection of devices or modules, and can be electrical, mechanical, or other forms.
[0097] Furthermore, in the various embodiments of the present invention, each functional module can be fully integrated into a processor, or each module can be a separate device, or two or more modules can be integrated into a device; each functional module in the various embodiments of the present invention can be implemented in hardware or in the form of hardware plus software functional units.
[0098] Those skilled in the art will understand that all or part of the steps of the above method embodiments can be implemented by program instructions and related hardware. The aforementioned program instructions can be stored in a computer-readable storage medium. When the program instructions are executed, they perform the steps of the above method embodiments. The aforementioned storage medium includes various media that can store program code, such as mobile storage devices, read-only memory (ROM), magnetic disks, or optical disks.
[0099] It should be understood that the use of terms such as "method," "apparatus," "unit," and / or "module" in this application is merely to distinguish one method of different components, elements, parts, sections, or assemblies at different levels. However, if other terms can achieve the same purpose, they may be replaced by other expressions.
[0100] As indicated in this application and claims, unless the context clearly indicates otherwise, the words "a," "an," "a," and / or "the" are not specifically singular and may include the plural. Generally, the terms "comprising" and "including" only indicate the inclusion of expressly identified steps and elements, which do not constitute an exclusive list, and the method or apparatus may also include other steps or elements. An element defined by the phrase "comprising an..." does not exclude the presence of other identical elements in the process, method, product, or apparatus that includes the element.
[0101] Hereinafter, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature.
[0102] If a flowchart is used in this application, it is used to illustrate the operations performed by the system according to embodiments of this application. It should be understood that the preceding or following operations are not necessarily performed in exact order. Instead, the steps can be processed in reverse order or simultaneously. Furthermore, other operations can be added to these processes, or one or more steps can be removed from them.
[0103] The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A method for changing the usage scenario of a CGM device, characterized in that, Includes the following steps: Upon receiving a scene transition command from a patient, retrieve the unique serial number of the CGM device worn by the patient in the first scene; The current parameters of the CGM device are obtained based on the unique number; If the current parameter is less than the usage period of the CGM device, then an authorization key for the second scenario is automatically generated based on the current parameter; The patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorization key until the CGM device usage cycle ends. The current parameters include the duration of use, device model, and sensor model. The authorization key is a barcode or a QR code.
2. The method for changing the usage scenario of CGM equipment according to claim 1, characterized in that, The first scenario is the usage scenario of the CGM device in its first cycle.
3. The method for changing the usage scenario of CGM equipment according to claim 2, characterized in that, The second scenario is the usage scenario of the second cycle following the first cycle.
4. The method for changing the usage scenario of CGM equipment according to claim 1, characterized in that, Before obtaining the current parameters of the CGM device based on the unique number, the method further includes the following steps: The CGM management module sends the unique number and scene conversion instruction to the Bluetooth gateway, and the Bluetooth gateway disconnects from the CGM device based on the unique number and scene conversion instruction.
5. The method for changing the usage scenario of CGM equipment according to claim 4, characterized in that, The step of obtaining the current parameters of the CGM device based on the unique number specifically includes: After the Bluetooth gateway successfully disconnects, the CGM management module calculates the current parameters of the CGM device.
6. The method for changing the usage scenario of CGM equipment according to claim 1, characterized in that, The authorization key includes: the device's unique serial number, remaining usage time, device connection instructions, and the latest blood glucose data.
7. The method for changing the usage scenario of CGM equipment according to claim 6, characterized in that, The patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorized key until the CGM device's usage cycle ends, specifically including: The patient scans the authorization key through a user terminal to obtain the device's unique serial number, device connection instructions, and remaining usage time. The user terminal decodes the acquired unique device number, device connection command, and remaining usage time.
8. The method for changing the usage scenario of CGM equipment according to claim 7, characterized in that, The patient continues to use the CGM device for blood glucose monitoring in the second scenario using the authorized key until the end of the CGM device's usage cycle, which also specifically includes: The user terminal verifies the decoded information: If the verification passes, a connection command is sent to the CGM device to bind the CGM device; Once the binding is successful, the patient continues to use the CGM device for blood glucose monitoring in the second scenario until the CGM device usage cycle ends.
9. A usage scenario conversion system for a CGM device, based on the method described in any one of claims 1 to 8, characterized in that, include: CGM management module, Bluetooth gateway, and user terminal; The CGM management module is connected to the CGM device, the Bluetooth gateway, and the user terminal, respectively. The Bluetooth gateway is connected to the CGM device; The CGM management module is used to query the unique number of the CGM device worn by the patient in the first scenario when it receives the scene switching instruction from the patient, and send the unique device number and the scene switching instruction to the Bluetooth gateway. The CGM management module is also used to automatically generate an authorization key for the second scenario based on the current parameters if the current parameters of the CGM device are less than the usage cycle of the CGM device. The Bluetooth gateway is configured to stop receiving blood glucose data detected by the CGM device and disconnect the Bluetooth connection of the CGM device after receiving the scene switching instruction. The user terminal is used to scan the authorization key, enabling the patient to continue using the CGM device for blood glucose monitoring in the second scenario until the CGM device's usage cycle ends.
Citation Information
Patent Citations
Near Field Telemetry Link for Passing a Shared Secret to Establish a Secure Radio Frequency Communication Link in a Physiological Condition Monitoring System
US20140313052A1